Tanghetti, Emil
-
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Acne & Rosacea
Improvements in Acne and Skin Oiliness with Tazarotene 0.045% Lotion in Acne Patients with Oily Skin
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Dermatopharmacology
A Comparative Clinical Demonstration of the Spreadability of Tazarotene Lotion 0.045% versus Trifarotene Cream 0.005%
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®) - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion for the Treatment of Plaque Psoriasis in Patients with Mild Scaling and Mild Plaque Elevation
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 5 No. 6 (2021): November Issue & Poster Presentations (FC21 Dermatology Conference®) - Acne & Rosacea
Tazarotene 0.045% Lotion for Acne: Formulation, Application Characteristics, and Clinical Efficacy and Safety
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 4 (2023): July Issue & Posters from FCPANP 23 - Dermatopharmacology
Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 1 No. 3 (2017) - Original Research
Ingenol Mebutate 0.06% Gel for Field Treatment of Actinic Keratosis on 250 cm2 of Skin on Trunk and Extremities: A Randomized Dose-Finding Trial
Abstract
Full Article PDF
Supplementary Material PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 4 (2022): July 2022 Issue - Acne & Rosacea
Vehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 2 (2024): March 2024 Issue - Acne & Rosacea
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Clinical Efficacy and Application Characteristics
Abstract
PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Acne & Rosacea
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Randomized Phase 2 and Phase 3 Studies of the First Triple-Combination Drug
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference® - Acne & Rosacea
Comparison of Cutaneous Irritation With Repeated Application of Tazarotene 0.045% Lotion, Adapalene 0.3% Gel, and Trifarotene 0.005% Cream
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Acne & Rosacea
Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Different Adult Age Groups
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Acne & Rosacea
Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 1 (2024): January 2024 Issue - Acne & Rosacea
Safety and Tolerability of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants With Acne
Abstract
PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 4 (2023): July Issue & Posters from FCPANP 23 - Acne & Rosacea
Safety of Tazarotene 0.045% Lotion and Hyperpigmentation Improvements in Black Participants With Moderate-to-Severe Acne
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference) - Acne & Rosacea
Trifarotene 50 µg/G Cream for Treatment of Acne Vulgaris – A Summary of Two Randomized Trials and a Long-Term Safety Study
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 8 No. 2 (2024): March 2024 Issue - Acne & Rosacea
Efficacy and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne Vulgaris in Children and Adolescents
Abstract
PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 1 (2017): Supplemental Issue: Scientific Posters Presented at 2017 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
Efficacy and Saftey of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Doxycycline in Subjects with Severe Inflammatory Acne (Non-Nodulocystic) that are Candidates for Oral Isotretinoin
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 7 No. 4 (2023): July Issue & Posters from FCPANP 23 - Acne & Rosacea
Impact of Age or Sex on Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Participants with Moderate-to-Severe Acne
Abstract
Poster PDF
-
SKIN The Journal of Cutaneous Medicine Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®) - Acne & Rosacea
Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Phase 2 Study of the First Triple-Combination Drug
Abstract
Poster PDF